Hoth Therapeutics Ownership 2024 | Who Owns Hoth Therapeutics Now?

Overview RevenueFinancials Chart

Institutional Ownership

0.00%

Insider Ownership

0.92%

Retail Ownership

99.07%

Institutional Holders

2.00

Hoth Therapeutics Institutional Shareholders

Institutional Shareholders by % of Total Shares

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
ADVISORNET FINANCIAL, INC	-	-	-	-7	-100.00%	-	Mar 31, 2024
FARTHER FINANCE ADVISORS, LLC	-	-	-	-1	-100.00%	-	Mar 31, 2024

Hoth Therapeutics's largest institutional shareholder is ADVISORNET FINANCIAL, INC, holding 0.00% of the company's total share outstanding, currently valued at -. The top 10 institutional shareholders own together 0.00% of the company.

Institutional Shareholders by % of Total Assets

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
ADVISORNET FINANCIAL, INC	-	-	-	-7	-100.00%	-	Mar 31, 2024
FARTHER FINANCE ADVISORS, LLC	-	-	-	-1	-100.00%	-	Mar 31, 2024

The largest Hoth Therapeutics shareholder by % of total assets is ADVISORNET FINANCIAL, INC. The company owns 0.00 shares of Hoth Therapeutics (HOTH), representing 0.00% of its total assets.

Institutional Buyers

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
FARTHER FINANCE ADVISORS, LLC	-	-	-	-1	-100.00%	-	Mar 31, 2024
ADVISORNET FINANCIAL, INC	-	-	-	-7	-100.00%	-	Mar 31, 2024

As of Mar 31 2024, Hoth Therapeutics's largest institutional buyer is FARTHER FINANCE ADVISORS, LLC. The company purchased -1.00 stocks of HOTH, valued at -.

Institutional Sellers

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
ADVISORNET FINANCIAL, INC	-	-	-	-7	-100.00%	-	Mar 31, 2024
FARTHER FINANCE ADVISORS, LLC	-	-	-	-1	-100.00%	-	Mar 31, 2024

As of Mar 31 2024, Hoth Therapeutics's biggest institutional seller is ADVISORNET FINANCIAL, INC. The company sold -7.00 shares of HOTH, valued at -.

Institutional New positions

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date

Institutional Sold Out

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
ADVISORNET FINANCIAL, INC	-	-	-	-7	-100.00%	-	Mar 31, 2024
FARTHER FINANCE ADVISORS, LLC	-	-	-	-1	-100.00%	-	Mar 31, 2024

Hoth Therapeutics's largest sold out institutional shareholder by shares sold is ADVISORNET FINANCIAL, INC, sold -7.00 shares, valued at -, as of undefined.

Hoth Therapeutics Mutual Fund Holders

Name	% Total Assets	Total Shares	Change Amount	Change %	Date
VANGUARD INDEX FUNDS	0.00%	942,305	-	-	Mar 31, 2024
FIDELITY CONCORD STREET TRUST	0.00%	132,041	-	-	Feb 29, 2024
FIDELITY CONCORD STREET TRUST	0.00%	21,932	1,979	9.92%	Feb 29, 2024
VANGUARD INDEX FUNDS	0.00%	38,804	-38,804	-50.00%	Mar 31, 2024
USAA MUTUAL FUNDS TRUST	0.00%	2,861	-	-	Jan 31, 2024
EQ ADVISORS TRUST	0.00%	4,669	-	-	Mar 31, 2024
JOHN HANCOCK VARIABLE INSURANCE TRUST	0.00%	3,937	-	-	Mar 31, 2024
DFA INVESTMENT DIMENSIONS GROUP INC	0.00%	664	-	-	Jan 31, 2024

Hoth Therapeutics's largest mutual fund holder by % of total assets is "VANGUARD INDEX FUNDS", owning 942.30K shares, compromising 0.00% of its total assets.

Hoth Therapeutics Institutional Ownership Trends

Institutional Holdings Trend

Date	Holdings	Change %
31 Dec, 23	2	-
30 Sep, 23	2	100.00%
30 Jun, 23	1	-
31 Mar, 23	1	-
31 Dec, 22	1	-91.67%
30 Sep, 22	12	-7.69%
30 Jun, 22	13	-27.78%
31 Mar, 22	18	28.57%
31 Dec, 21	14	40.00%
30 Sep, 21	10	-
30 Jun, 21	10	-37.50%
31 Mar, 21	16	33.33%
31 Dec, 20	12	50.00%
30 Sep, 20	8	-38.46%
30 Jun, 20	13	333.33%
31 Mar, 20	3	-25.00%
31 Dec, 19	4	-
30 Sep, 19	4	33.33%
30 Jun, 19	3	-25.00%
31 Mar, 19	4	-

As of 31 Dec 23, 2 institutions are holding Hoth Therapeutics's shares, representing an increase of 0.00% compared to the previous quarter.

Shares Outstanding Trend

Date	Shares Outstanding	Change %
31 Dec, 23	8	-
30 Sep, 23	8	14.29%
30 Jun, 23	7	-
31 Mar, 23	7	-
31 Dec, 22	7	-100.00%
30 Sep, 22	1,435,212	2.99%
30 Jun, 22	1,393,513	-0.10%
31 Mar, 22	1,394,957	6.66%
31 Dec, 21	1,307,856	24.88%
30 Sep, 21	1,047,297	5.79%
30 Jun, 21	989,933	-67.42%
31 Mar, 21	3,038,802	766.41%
31 Dec, 20	350,733	78.28%
30 Sep, 20	196,731	-27.92%
30 Jun, 20	272,925	733.54%
31 Mar, 20	32,743	-4.24%
31 Dec, 19	34,193	100.35%
30 Sep, 19	17,067	470.42%
30 Jun, 19	2,992	-82.50%
31 Mar, 19	17,101	-

Hoth Therapeutics (HOTH) has 8.00 shares outstanding as of 31 Dec 23, up 0.00% compared to the previous quarter.

Institutional Ownership Trend

Date	Ownership %	Change %
31 Dec, 23	0.00%	473950.00%
30 Sep, 23	0.00%	286433.33%
30 Jun, 23	0.00%	333333.33%
31 Mar, 23	0.00%	333333.33%
31 Dec, 22	0.00%	0.00%
30 Sep, 22	4.46%	22.10%
30 Jun, 22	4.49%	13.26%
31 Mar, 22	5.82%	16.96%
31 Dec, 21	5.86%	30.47%
30 Sep, 21	4.38%	25.12%
30 Jun, 21	4.18%	1.41%
31 Mar, 21	17.19%	213.58%
31 Dec, 20	2.84%	132.31%
30 Sep, 20	1.46%	29.76%
30 Jun, 20	2.22%	2174.23%
31 Mar, 20	0.32%	229.46%
31 Dec, 19	0.37%	1252.20%
30 Sep, 19	0.17%	17758.33%
30 Jun, 19	0.03%	52.34%
31 Mar, 19	0.24%	-

As of 31 Dec 23, Hoth Therapeutics is held by 0.00% institutional shareholders, representing a 473950.00% growth compared to 30 Sep 23.

Institutional Increased Positions Trend

Date	Increased Positions	Change %
31 Dec, 23	-	-100.00%
30 Sep, 23	1	-
30 Jun, 23	-	-
31 Mar, 23	-	-100.00%
31 Dec, 22	1	-80.00%
30 Sep, 22	5	-16.67%
30 Jun, 22	6	-33.33%
31 Mar, 22	9	50.00%
31 Dec, 21	6	20.00%
30 Sep, 21	5	-16.67%
30 Jun, 21	6	-50.00%
31 Mar, 21	12	50.00%
31 Dec, 20	8	60.00%
30 Sep, 20	5	-61.54%
30 Jun, 20	13	1200.00%
31 Mar, 20	1	-75.00%
31 Dec, 19	4	33.33%
30 Sep, 19	3	-
30 Jun, 19	3	-25.00%
31 Mar, 19	4	-

- institutional shareholders have increased their position in HOTH stock as of 31 Dec 23 compared to 1 in the previous quarter (a -100.00% decrease).

Institutional Reduced Positions Trend

Date	Reduced Positions	Change %
31 Dec, 23	-	-
30 Sep, 23	-	-
30 Jun, 23	-	-
31 Mar, 23	-	-
31 Dec, 22	-	-100.00%
30 Sep, 22	2	-33.33%
30 Jun, 22	3	-50.00%
31 Mar, 22	6	-
31 Dec, 21	-	-100.00%
30 Sep, 21	1	-
30 Jun, 21	1	-
31 Mar, 21	1	-
31 Dec, 20	-	-100.00%
30 Sep, 20	1	-
30 Jun, 20	-	-100.00%
31 Mar, 20	2	-
31 Dec, 19	-	-100.00%
30 Sep, 19	1	-
30 Jun, 19	-	-
31 Mar, 19	-	-

- institutional shareholders have reduced their position in HOTH stock as of 31 Dec 23 compared to - in the previous quarter (a 0.00% increase).

All Institutional Ownership Trend Data

Date	Holdings	Change %	Shares Outstanding	Change %	Ownership %	Change %	Increased Positions	Change %	Reduced Positions	Change %
31 Dec, 23	2	-	8	-	0.00%	473950.00%	-	-100.00%	-	-
30 Sep, 23	2	100.00%	8	14.29%	0.00%	286433.33%	1	-	-	-
30 Jun, 23	1	-	7	-	0.00%	333333.33%	-	-	-	-
31 Mar, 23	1	-	7	-	0.00%	333333.33%	-	-100.00%	-	-
31 Dec, 22	1	-91.67%	7	-100.00%	0.00%	0.00%	1	-80.00%	-	-100.00%
30 Sep, 22	12	-7.69%	1,435,212	2.99%	4.46%	22.10%	5	-16.67%	2	-33.33%
30 Jun, 22	13	-27.78%	1,393,513	-0.10%	4.49%	13.26%	6	-33.33%	3	-50.00%
31 Mar, 22	18	28.57%	1,394,957	6.66%	5.82%	16.96%	9	50.00%	6	-
31 Dec, 21	14	40.00%	1,307,856	24.88%	5.86%	30.47%	6	20.00%	-	-100.00%
30 Sep, 21	10	-	1,047,297	5.79%	4.38%	25.12%	5	-16.67%	1	-
30 Jun, 21	10	-37.50%	989,933	-67.42%	4.18%	1.41%	6	-50.00%	1	-
31 Mar, 21	16	33.33%	3,038,802	766.41%	17.19%	213.58%	12	50.00%	1	-
31 Dec, 20	12	50.00%	350,733	78.28%	2.84%	132.31%	8	60.00%	-	-100.00%
30 Sep, 20	8	-38.46%	196,731	-27.92%	1.46%	29.76%	5	-61.54%	1	-
30 Jun, 20	13	333.33%	272,925	733.54%	2.22%	2174.23%	13	1200.00%	-	-100.00%
31 Mar, 20	3	-25.00%	32,743	-4.24%	0.32%	229.46%	1	-75.00%	2	-
31 Dec, 19	4	-	34,193	100.35%	0.37%	1252.20%	4	33.33%	-	-100.00%
30 Sep, 19	4	33.33%	17,067	470.42%	0.17%	17758.33%	3	-	1	-
30 Jun, 19	3	-25.00%	2,992	-82.50%	0.03%	52.34%	3	-25.00%	-	-
31 Mar, 19	4	-	17,101	-	0.24%	-	4	-	-	-

Hoth Therapeutics Insider Shareholders Trades

Open Market Insider Trades

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held	Source
Sep 20, 2022	Knie Robb	director, officer	CEO and President	P-Purchase	Buy	10,000	$0.39	$3.90K	828,259
Sep 19, 2022	Knie Robb	director, officer	CEO and President	P-Purchase	Buy	10,000	$0.40	$4.00K	818,259

Open Market Insider Buys

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held	Source
Sep 20, 2022	Knie Robb	director, officer	CEO and President	P-Purchase	Buy	10,000	$0.39	$3.90K	828,259
Sep 19, 2022	Knie Robb	director, officer	CEO and President	P-Purchase	Buy	10,000	$0.40	$4.00K	818,259

Insider Sells

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held	Source

All Insider Owners Trades

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held
Jan 08, 2024	Springer Graig	director	-	A-Award	Buy	100,000	$1.36	$136.00K	100,000
Jan 08, 2024	Springer Graig	director	-	A-Award	Buy	25,000	$1.36	$34.00K	25,000
Jan 08, 2024	Sarnoff David	director	-	A-Award	Buy	25,000	$1.36	$34.00K	25,000
Jan 08, 2024	Pavell Jeff	director	-	A-Award	Buy	25,000	$1.36	$34.00K	25,000
Jan 08, 2024	Linsley Wayne	director	-	A-Award	Buy	25,000	$1.36	$34.00K	25,000
Jan 08, 2024	Knie Robb	director, officer	CEO and President	A-Award	Buy	225,000	$1.36	$306.00K	225,000
Jul 18, 2023	Sarnoff David	director	-	A-Award	Buy	7,500	$2.59	$19.43K	7,500
Jul 18, 2023	Springer Graig	director	-	A-Award	Buy	20,000	$2.59	$51.80K	20,000
Jul 18, 2023	Springer Graig	director	-	A-Award	Buy	7,500	$2.59	$19.43K	7,500
Jul 18, 2023	Knie Robb	director, officer	CEO and President	A-Award	Buy	40,000	$2.59	$103.60K	40,000
Jul 18, 2023	Pavell Jeff	director	-	A-Award	Buy	7,500	$2.59	$19.43K	7,500
Jul 18, 2023	Linsley Wayne	director	-	A-Award	Buy	7,500	$2.59	$19.43K	7,500
Dec 13, 2022	Pavell Jeff	director	-	A-Award	Buy	5,075	-	-	5,075
Dec 13, 2022	Pavell Jeff	-	-		Buy	-	-	-	-
Dec 13, 2022	Pavell Jeff	director			Buy	-	-	-	-
Sep 20, 2022	Knie Robb	director, officer	CEO and President	P-Purchase	Buy	10,000	$0.39	$3.90K	828,259
Sep 19, 2022	Knie Robb	director, officer	CEO and President	P-Purchase	Buy	10,000	$0.40	$4.00K	818,259
Mar 18, 2022	Knie Robb	officer	CEO and President	A-Award	Buy	500,000	-	-	500,000
Mar 18, 2022	Knie Robb	director, officer	CEO and President	A-Award	Buy	500,000	$0.59	$295.50K	500,000
Mar 18, 2022	Johns Stefanie	officer	Chief Scientific Officer	A-Award	Buy	250,000	-	-	250,000

The last insider buy of HOTH was made by Knie Robb on Sep 20 2022, buying 10,000 shares at $0.39 per share (worth $3.90K).

Hoth Therapeutics Insider Ownership Trends

All Insider Trades Trend

Date	Buy	Sell	Buy/Sell Ratio
Q3 2023	6	-	-
Q4 2022	1	-	-
Q1 2022	5	-	-
Q1 2021	7	-	-
Q4 2020	-	-	-
Q3 2020	7	-	-
Q2 2020	2	2	100.00%
Q1 2020	-	-	-
Q4 2019	5	-	-
Q1 2019	3	11	27.27%
Q4 2017	-	2	-

6 total buy trades, and 0 total sell trades (buy/sell ratio of 0%) were made by Hoth Therapeutics's insiders, as of Q3 2023.

Open Market Insider Trades Trend

Date	Buy	Sell	Buy/Sell Ratio
Q3 2023	-	-	-
Q4 2022	-	-	-
Q1 2022	-	-	-
Q1 2021	-	-	-
Q4 2020	-	-	-
Q3 2020	-	-	-
Q2 2020	-	2	-
Q1 2020	-	-	-
Q4 2019	-	-	-
Q1 2019	-	-	-
Q4 2017	-	-	-

As of Q3 2023, Insider owners conducted 0 open market buy trades and 0 open market sell trades of Hoth Therapeutics's stocks.

Hoth Therapeutics Peer Ownership

Ticker	Company
BDRX	Biodexa Pharmaceuticals Plc
BWV	Onconetix, Inc.
KPRX	Kiora Pharmaceuticals, Inc.
PHIO	Phio Pharmaceuticals Corp.
ADTX	Aditxt, Inc.
REVB	Revelation Biosciences, Inc.
QNRX	Quoin Pharmaceuticals, Ltd.
HILS	Tharimmune, Inc.
VRAX	Virax Biolabs Group Limited
ALLR	Allarity Therapeutics, Inc.
NRBO	NeuroBo Pharmaceuticals, Inc.
SONN	Sonnet BioTherapeutics Holdings, Inc.
ATXI	Avenue Therapeutics, Inc.
BXRX	Baudax Bio, Inc.
ZURA	Zura Bio Limited
CDIO	Cardio Diagnostics Holdings, Inc.
ATNF	180 Life Sciences Corp.

HOTH Ownership FAQ

Who Owns Hoth Therapeutics?

Hoth Therapeutics is owned by institutional shareholders (0.00%), insiders (0.92%), and public (99.07%). The largest institutional shareholder of Hoth Therapeutics is ADVISORNET FINANCIAL, INC (0% of total shares) and the top mutual fund owner is VANGUARD INDEX FUNDS (0.00% of total shares).

Who are the major institutional shareholders of Hoth Therapeutics?

Hoth Therapeutics's major institutional shareholders are ADVISORNET FINANCIAL, INC, and FARTHER FINANCE ADVISORS, LLC. The top five shareholders own together 0% of the company's share outstanding.

How many Hoth Therapeutics shareholders are there?

As of Dec 2023, there are 2 institutional shareholders of Hoth Therapeutics.

What percentage of Hoth Therapeutics is owned by ADVISORNET FINANCIAL, INC?

ADVISORNET FINANCIAL, INC owns 0 shares of Hoth Therapeutics, representing 0% of the company's total shares outstanding, valued at $0 (as of Mar 2024).

What percentage of Hoth Therapeutics is owned by FARTHER FINANCE ADVISORS, LLC?

As of Mar 2024, FARTHER FINANCE ADVISORS, LLC holds 0 shares of Hoth Therapeutics (HOTH), compromising 0% of the company, valued at $0.